Thromboelastography in Veterinary Medicine

 

 Buy Article Permissions and Reprints

ABSTRACT

Thromboelastography (TEG) has been used in experimental animal studies since the early 1960s and in a routine clinical setting for the past decade. From the data currently available, it is clear that both the scope and limitations of TEG in animals resemble those observed in humans. TEG has been used to diagnose hypercoagulability in animals with disseminated intravascular coagulation, various types of cancer, and critical illness. Its ability to detect and monitor animals with various types of coagulopathies has been well established, both clinically and in experimental studies. TEG is often used in animals to monitor the effect of different pro- and anticoagulant drugs and often performs better at this task than conventional coagulation assays. TEG is already well established in veterinary medicine, and with the rapid dissemination of the technique currently taking place, we can expect to see a wide variety of interesting animal data published in the near future.

REFERENCES

• 1 Butenas S, Branda R F, van't Veer C, Cawthern K M, Mann K G. Platelets and phospholipids in tissue factor-initiated thrombin generation.  Thromb Haemost. 2001;  86(2) 660-667
  PubMedGoogle Scholar
• 2 Hemker H C, van Rijn J L, Rosing J, van Dieijen G, Bevers E M, Zwaal R F. Platelet membrane involvement in blood coagulation.  Blood Cells. 1983;  9(2) 303-317
  PubMedGoogle Scholar
• 3 Hoffman M, Monroe III D M. A cell-based model of hemostasis.  Thromb Haemost. 2001;  85(6) 958-965
  PubMedGoogle Scholar
• 4 McVey J H. Tissue factor pathway.  Baillieres Best Pract Res Clin Haematol. 1999;  12(3) 361-372
  CrossrefPubMedGoogle Scholar
• 5 Rosing J, van Rijn J L, Bevers E M, van Dieijen G, Comfurius P, Zwaal R F. The role of activated human platelets in prothrombin and factor X activation.  Blood. 1985;  65(2) 319-332
  PubMedGoogle Scholar
• 6 Burstein S A, Peng J, Friese P et al.. Cytokine-induced alteration of platelet and hemostatic function.  Stem Cells. 1996;  14(Suppl 1) 154-162
  CrossrefPubMedGoogle Scholar
• 7 Franco R F, de Jonge E, Dekkers P E et al.. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation.  Blood. 2000;  96(2) 554-559
  PubMedGoogle Scholar
• 8 Levi M, de Jonge E, van der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology.  Ann Med. 2004;  36(1) 41-49
  PubMedGoogle Scholar
• 9 Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis.  Thromb Haemost. 1983;  49(1) 5-7
  PubMedGoogle Scholar
• 10 Wiinberg B, Jensen A L, Kjelgaard-Hansen M et al.. Study on biological variation of haemostatic parameters in clinically healthy dogs.  Vet J. 2007;  174(1) 62-68
  CrossrefPubMedGoogle Scholar
• 11 Lindblad B, Borgström A, Wakefield T W, Whitehouse Jr W M, Stanley J C. Haemodynamic and haematologic alterations with protamine reversal of anticoagulation: comparison of standard heparin and a low molecular weight heparin fragment.  Eur J Vasc Surg. 1987;  1(3) 181-185
  CrossrefPubMedGoogle Scholar
• 12 Logan J C, Callan M B, Drew K et al.. Clinical indications for use of fresh frozen plasma in dogs: 74 dogs (October through December 1999).  J Am Vet Med Assoc. 2001;  218(9) 1449-1455
  CrossrefPubMedGoogle Scholar
• 13 Palmer K G, King L G, Van Winkle T J. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989–1996).  J Am Vet Med Assoc. 1998;  213(2) 220-224
  PubMedGoogle Scholar
• 14 Ross S J, Smith S A, Lekcharoensuk C. Disseminated intravascular coagulation (DIC) in dogs: 252 cases (1999–2000).  J Vet Intern Med. 2002;  16(3) 322
  PubMedGoogle Scholar
• 15 Bauer N, Eralp O, Moritz A. Establishment of reference intervals for kaolin-activated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use.  J Vet Diagn Invest. 2009;  21(5) 641-648
  CrossrefPubMedGoogle Scholar
• 16 Vilar P, Couto C G, Westendorf N, Iazbik C, Charske J, Marín L. Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs.  J Vet Intern Med. 2008;  22(2) 374-379
  CrossrefPubMedGoogle Scholar
• 17 Wiinberg B, Jensen A L, Rojkjaer R, Johansson P, Kjelgaard-Hansen M, Kristensen A T. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs.  Vet Clin Pathol. 2005;  34(4) 389-393
  CrossrefPubMedGoogle Scholar
• 18 Epstein K L, Brainard B M, Lopes M A, Barton M H, Moore J N. Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factor.  J Vet Emerg Crit Care (San Antonio). 2009;  19(1) 96-101
  CrossrefPubMedGoogle Scholar
• 19 Paltrinieri S, Meazza C, Giordano A, Tunesi C. Validation of thromboelastometry in horses.  Vet Clin Pathol. 2008;  37(3) 277-285
  CrossrefPubMedGoogle Scholar
• 20 Leclere M, Lavoie J P, Dunn M, Bédard C. Evaluation of a modified thrombelastography assay initiated with recombinant human tissue factor in clinically healthy horses.  Vet Clin Pathol. 2009;  38(4) 462-466
  CrossrefPubMedGoogle Scholar
• 21 Velik-Salchner C, Schnürer C, Fries D et al.. Normal values for thrombelastography (ROTEM) and selected coagulation parameters in porcine blood.  Thromb Res. 2006;  117(5) 597-602
  CrossrefPubMedGoogle Scholar
• 22 Horn N A, Hecker K E, Bongers B, Baumert H J, Reyle-Hahn S M, Rossaint R. Coagulation assessment in healthy pigs undergoing single xenon anaesthesia and combinations with isoflurane and sevoflurane.  Acta Anaesthesiol Scand. 2001;  45(5) 634-638
  CrossrefPubMedGoogle Scholar
• 23 Palsgaard-Van Lue A, Strøm H, Lee M H et al.. Cellular, hemostatic, and inflammatory parameters of the surgical stress response in pigs undergoing partial pericardectomy via open thoracotomy or thoracoscopy.  Surg Endosc. 2007;  21(5) 785-792
  CrossrefPubMedGoogle Scholar
• 24 Anagnostopoulos P V, Shepard A D, Pipinos I I et al.. Analysis of coagulation changes associated with supraceliac aortic crossclamping using thromboelastography.  J Surg Res. 2001;  98(1) 52-58
  CrossrefPubMedGoogle Scholar
• 25 King D R, Cohn S M, Feinstein A J, Proctor K G. Systemic coagulation changes caused by pulmonary artery catheters: laboratory findings and clinical correlation.  J Trauma. 2005;  59(4) 853-857; discussion 857–859
  CrossrefPubMedGoogle Scholar
• 26 Tomori T, Hupalo D, Teranishi K et al.. Evaluation of coagulation stages of hemorrhaged swine: comparison of thromboelastography and rotational elastometry.  Blood Coagul Fibrinolysis. 2010;  21(1) 20-27
  CrossrefPubMedGoogle Scholar
• 27 Siller-Matula J M, Plasenzotti R, Spiel A, Quehenberger P, Jilma B. Interspecies differences in coagulation profile.  Thromb Haemost. 2008;  100(3) 397-404
  PubMedGoogle Scholar
• 28 Moalic P, Gruel Y, Foloppe P, Delahousse B, Leclerc M H, Leroy J. Hemostasis development in the lamb fetus and neonate.  Am J Vet Res. 1989;  50(1) 59-63
  PubMedGoogle Scholar
• 29 Nielsen V G, Geary B T, Baird M S. Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D.  Anesth Analg. 2000;  91(1) 35-39
  CrossrefPubMedGoogle Scholar
• 30 Shibata J, Hasegawa J, Siemens H J et al.. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis.  Blood. 2003;  101(11) 4416-4422
  CrossrefPubMedGoogle Scholar
• 31 Wiinberg B, Jensen A L, Rozanski E et al.. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs.  Vet J. 2009;  179(1) 121-129
  CrossrefPubMedGoogle Scholar
• 32 Wiinberg B, Jensen A L, Johansson P I, Rozanski E, Tranholm M, Kristensen A T. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation.  J Vet Intern Med. 2008;  22(2) 357-365
  CrossrefPubMedGoogle Scholar
• 33 Wagg C R, Boysen S R, Bédard C. Thrombelastography in dogs admitted to an intensive care unit.  Vet Clin Pathol. 2009;  38(4) 453-461
  CrossrefPubMedGoogle Scholar
• 34 Otto C M, Rieser T M, Brooks M B, Russell M W. Evidence of hypercoagulability in dogs with parvoviral enteritis.  J Am Vet Med Assoc. 2000;  217(10) 1500-1504
  CrossrefPubMedGoogle Scholar
• 35 Kristensen A T, Wiinberg B, Jessen L R, Andreasen E, Jensen A L. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia.  J Vet Intern Med. 2008;  22(1) 140-147
  CrossrefPubMedGoogle Scholar
• 36 Johansson P I, Stensballe J, Vindeløv N, Perner A, Espersen K. Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality.  Blood Coagul Fibrinolysis. 2010;  21(2) 168-174
  CrossrefPubMedGoogle Scholar
• 37 Sinnott V B, Otto C M. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000–2008).  J Vet Emerg Crit Care (San Antonio). 2009;  19(5) 484-488
  CrossrefPubMedGoogle Scholar
• 38 Brooks M B, Randolph J, Warner K, Center S. Evaluation of platelet function screening tests to detect platelet procoagulant deficiency in dogs with Scott syndrome.  Vet Clin Pathol. 2009;  38(3) 306-315
  CrossrefPubMedGoogle Scholar
• 39 Poller L, Thomson J M, Sear C H, Thomas W. Identification of a congenital defect of factor VII in a colony of beagle dogs: the clinical use of the plasma.  J Clin Pathol. 1971;  24(7) 626-632
  CrossrefPubMedGoogle Scholar
• 40 Callan M B, Aljamali M N, Margaritis P et al.. A novel missense mutation responsible for factor VII deficiency in research Beagle colonies.  J Thromb Haemost. 2006;  4(12) 2616-2622
  CrossrefPubMedGoogle Scholar
• 41 Macieira S, Rivard G E, Champagne J, Lavoie J P, Bédard C. Glanzmann thrombasthenia in an Oldenbourg filly.  Vet Clin Pathol. 2007;  36(2) 204-208
  CrossrefPubMedGoogle Scholar
• 42 Raina S, Spillert C R, Greenstein S M, Lazaro E J. Effect of surgery on tumor-induced accelerated coagulation in a rat carcinoma.  J Surg Res. 1985;  38(2) 138-142
  CrossrefPubMedGoogle Scholar
• 43 Haid M, Zuckerman L, Caprini J A, Kurtides S, Vagher P. Thromboelastographic changes in carcinoma: an animal model.  J Med. 1976;  7(3-4) 189-216
  PubMedGoogle Scholar
• 44 Mousa S A, Linhardt R, Francis J L, Amirkhosravi A. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin.  Thromb Haemost. 2006;  96(6) 816-821
  Google Scholar
• 45 Olrik Berthelsen L, Thuri Kristensen A, Wiinberg B, Tranholm M. Implementation of the ISTH classification of non-overt DIC in a thromboplastin induced rabbit model.  Thromb Res. 2009;  124(4) 490-497
  CrossrefPubMedGoogle Scholar
• 46 Kaspereit F, Doerr B, Dickneite G. The effect of fibrinogen concentrate administration on coagulation abnormalities in a rat sepsis model.  Blood Coagul Fibrinolysis. 2004;  15(1) 39-43
  CrossrefPubMedGoogle Scholar
• 47 Barklin A, Tønnesen E, Ingerslev J, Sørensen B, Fenger-Eriksen C. Coagulopathy during induced severe intracranial hypertension in a porcine donor model.  Anesthesiology. 2009;  110(6) 1287-1292
  CrossrefPubMedGoogle Scholar
• 48 Othman M, Powell S, Chirinian Y, Hegadorn C, Hopman W, Lillicrap D. Thromboelastography reflects global hemostatic variation among severe haemophilia A dogs at rest and following acute exercise.  Haemophilia. 2009;  15(5) 1126-1134
  CrossrefPubMedGoogle Scholar
• 49 Margaritis P, Roy E, Aljamali M N et al.. Successful treatment of canine hemophilia by continuous expression of canine FVIIa.  Blood. 2009;  113(16) 3682-3689
  CrossrefPubMedGoogle Scholar
• 50 Ao H, Moon J K, Tashiro M, Terasaki H. Delayed platelet dysfunction in prolonged induced canine hypothermia.  Resuscitation. 2001;  51(1) 83-90
  CrossrefPubMedGoogle Scholar
• 51 Kheirabadi B S, Crissey J M, Deguzman R, Holcomb J B. In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time.  J Trauma. 2007;  62(6) 1352-1359; discussion 1359–1361
  CrossrefPubMedGoogle Scholar
• 52 Alwood A J, Downend A B, Brooks M B et al.. Anticoagulant effects of low-molecular-weight heparins in healthy cats.  J Vet Intern Med. 2007;  21(3) 378-387
  CrossrefPubMedGoogle Scholar
• 53 Jessen L R, Wiinberg B, Jensen A L et al.. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time.  Vet Clin Pathol. 2008;  37(4) 363-372
  CrossrefPubMedGoogle Scholar
• 54 Vernese N A, Spillert C R, Franco C D, Lazaro E J. Thromboelastographic evaluation of mini-dose heparin in minor surgical procedures.  Am Surg. 1986;  52(2) 112-113
  PubMedGoogle Scholar
• 55 Nielsen V G. The detection of changes in heparin activity in the rabbit: a comparison of anti-Xa activity, thrombelastography, activated partial thromboplastin time, and activated coagulation time.  Anesth Analg. 2002;  95(6) 1503-1506
  CrossrefPubMedGoogle Scholar
• 56 Brainard B M, Meredith C P, Callan M B et al.. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs.  Am J Vet Res. 2007;  68(3) 251-257
  CrossrefPubMedGoogle Scholar
• 57 Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.  Blood Coagul Fibrinolysis. 2008;  19(6) 557-567
  CrossrefPubMedGoogle Scholar
• 58 Sumi H, Sasaki K, Toki N, Robbins K C. Oral administration of urokinase.  Thromb Res. 1980;  20(5–6) 711-714
  CrossrefPubMedGoogle Scholar
• 59 Summaria L, Sandesara J, Yang G, Vagher J P, Caprini J A. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.  Thromb Haemost. 1986;  56(1) 71-79
  PubMedGoogle Scholar
• 60 Flight S M, Masci P P, Lavin M F, Gaffney P J. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.  Blood Coagul Fibrinolysis. 2006;  17(5) 417-420
  CrossrefPubMedGoogle Scholar
• 61 Tranholm M, Rojkjaer R, Pyke C et al.. Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits.  Thromb Res. 2003;  109(4) 217-223
  CrossrefPubMedGoogle Scholar
• 62 Jankun J, Selman S H, Keck R W, Łysiak-Szydłowska W, Skrzypczak-Jankun E. Very long half-life plasminogen activator inhibitor type 1 reduces bleeding in a mouse model.  BJU Int. 2010;  105(10) 1469-1476
  CrossrefPubMedGoogle Scholar
• 63 Henry M, Davidson L, Cohen Z, McDonagh P F, Nolan P E, Ritter L S. Whole blood aggregation, coagulation, and markers of platelet activation in diet-induced diabetic C57BL/6J mice.  Diabetes Res Clin Pract. 2009;  84(1) 11-18
  CrossrefPubMedGoogle Scholar
• 64 White N J, Martin E J, Brophy D F, Ward K R. Coagulopathy and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitation.  Resuscitation. 2010;  81(1) 111-116
  CrossrefPubMedGoogle Scholar

Bo WiinbergD.V.M. Ph.D. 

Department of Small Animal Clinical Sciences, Faculty of Life Sciences, University of Copenhagen

16 Dyrlaegevej, DK-1870 Frederiksberg C., Denmark

Email: bwi@life.ku.dk